Shenogen Pharma Group
PrivateLast Round
Series E
Extension
Sep 27, 2023
Total Funding Raised
$45.04M
Company Overview
Shenogen Pharma Group is a biopharmaceutical company that develops and commercializes first-in-class therapeutics for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenogen Pharma Group Comparables
Compare Shenogen Pharma Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InnoCare Pharma Limited | 77% | |
| Evopoint Biosciences | 76% | |
| Zai Lab Limited | 74% | |
Shenogen Pharma Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E Extension | Sep 27, 2023 | ||||
| Strategic | Sep 1, 2019 | ||||
| Series C Extension | Apr 1, 2019 | ||||
| Series C Extension | Jan 1, 2019 | ||||
| Series C Extension | Jul 21, 2017 | ||||
Series B Extension | Dec 1, 2016 |
Shenogen Pharma Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boxin Capital | Strategic |
| Beijing Jinhuitong Investment Management Co., Ltd. | Strategic |
| IDG Capital | Series B, Series C |
| Zhongzhi Capital | Series C Extension |
| 和灵资本 | Series C Extension |
| Richlink Capital | Series B Extension |
| RCI Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 27, 2023
Raised Series E Extension round with Shenzhen New Henglida Capital Management.
- Apr 1, 2019
Raised Series C Extension round with Zhongzhi Capital.
Shenogen Pharma Group Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shenogen Pharma Group's valuation, stock price, and market status.